Evidence of meeting #148 for Industry, Science and Technology in the 42nd Parliament, 1st Session. (The original version is on Parliament’s site, as are the minutes.) The winning word was regulations.

A video is available from Parliament.

On the agenda

MPs speaking

Also speaking

David Goodman  Chief Executive Officer, Pharmascience
Karen Proud  President, Consumer Health Products Canada
Brian Lewis  President and Chief Executive Officer, MEDEC
Bob Masterson  President and Chief Executive Officer, Chemistry Industry Association of Canada
Alain Boisvert  Head, Government Affairs and Market Access, Pharmascience
Diana Johnson  Vice-President, Regulatory Affairs, MEDEC
Dan Albas  Central Okanagan—Similkameen—Nicola, CPC

10:25 a.m.

Liberal

John Oliver Liberal Oakville, ON

I just want to come back to MEDEC one more time.

Thank you, all, for your presentations. It's been very insightful.

Once you get your licensing at the federal level—and I've heard the issues and concerns there—then you need to go out to all the different health technologists. I served on OTAC, in Ontario, for three or four years. I know the cumbersome provincial-territorial environment.

Is there more that could be done to improve uptake and industry adoption of technology or new drugs? Could CADTH being doing more? Is there a federal role in that to coordinate provinces and territories better?

10:25 a.m.

President and Chief Executive Officer, MEDEC

Brian Lewis

One of the things we see is that when CADTH or OTAC comes out with a positive recommendation on a new technology, it's well done. The review is completed very effectively. But what happens is it gets into the system and the system doesn't adopt the product because of cost constraints within the hospital. People tend to look at one or two elements, but it's really a system problem. Even though we get a great recommendation, and there are several examples of it coming out of OTAC, those products get minimal adoption and minimal uptake.

One of the things we're looking at when we talk to ISED and other departments in the government is a role for the federal government to champion what's called “value-based health care” and to actually show examples and to actually help the community. The change management at the hospital level comes down to cash flow. When one budget exists within a hospital or a department in a hospital and the other budget is outside the hospital, the benefit of a truly valuable solution from a cost perspective is not seen. It will be from a patient perspective.

Does that answer your question?

10:25 a.m.

Liberal

John Oliver Liberal Oakville, ON

Yes, that's good. Thanks.

10:25 a.m.

Liberal

The Chair Liberal Dan Ruimy

That takes us to the end of our session today. Thank you for a very enlightening presentation and lots of good questions, lots of good answers. I think it will feed nicely into our report.

Thank you, all, very much for coming, and we are adjourned for the day.